论文部分内容阅读
血清中γ-谷氨酰转肽酶(γ-GT)主要来自肝脏,故在肝胆系统疾病中,血清γ-GT活力增高。为探讨其临床上的应用价值,我们对658例肝胆系统疾病和100例其他疾病及100例健康成人的血清进行γ-GT活性检测。现简要报告如下:
Serum γ-glutamyl transpeptidase (γ-GT) mainly from the liver, so in the hepatobiliary diseases, serum γ-GT activity increased. In order to explore its clinical value, we detected the activity of γ-GT in 658 cases of hepatobiliary diseases and 100 cases of other diseases and serum of 100 healthy adults. The brief report is as follows: